Takeshi Tsunoda
Otsuka Pharmaceutical Co., Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Takeshi Tsunoda as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05615363 · A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])Otsuka Pharmaceutical Co., Ltd. · completed · Cardiac Edema (CHF) · study director
- Ph3NCT05326347 · A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With SchizophreniaOtsuka Pharmaceutical Co., Ltd. · completed · Schizophrenia · study director
- Ph3NCT05325645 · Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute SchizophreniaOtsuka Pharmaceutical Co., Ltd. · recruiting · Acute Schizophrenia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:16 UTC. The ranking covers the 200 most relevant of 41 PubMed records, and a shared surname and initials can bring in a namesake. All 41 on PubMed
- 1,390 citationsRCR 30.7
- Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.Clin Cancer Res · 2005191 citationsRCR 4.0
- 142 citationsRCR 4.1
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.J Transl Med · 2012120 citationsRCR 2.7
- 117 citationsRCR 2.5
- 95 citationsRCR 2.0
- 92 citationsRCR 2.7
- Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients.J Transl Med · 201480 citationsRCR 2.0
- Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia.Intern Med · 201079 citationsRCR 3.0
- Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study.Cancer Sci · 201576 citationsRCR 2.0